BioMarin
Highly Engaged Employees
Chemicals & Related Products · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
770 Lindaro St, San Rafael, California, ...Phone Number
(415) 506-6700Website
www.biomarin.comRevenue
$3.4 BillionStock Symbol
BMRNIndustry
About BioMarin
BioMarin Pharmaceutical Inc. is a global biotechnology company headquartered in San Rafael, California, founded in 1997. The company develops and commercializes therapies for rare, genetically defined diseases, with a focus on enzyme replacement and other specialized treatments. Its portfolio includes therapies for mucopolysaccharidosis, phenylketonuria, achondroplasia, severe hemophilia A, and Batten disease, with products marketed under brands including Vimizim, Naglazyme, Kuvan, Palynziq, Brineura, Voxzogo, Aldurazyme, and Roctavian. BioMarin operates manufacturing facilities in the U.S. and Ireland and distributes its products globally.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: BMRNShow moreBioMarin Org Chart
Compare Similar Companies to BioMarin
Compare insights from companies similar to BioMarin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$1.7B
1K - 5K
Private
$18M
1992
MO
Moh-Lim OngDirector, Business Planning & Operations Medical Office Chief & Chief Marketing Officer
BioMarin Tech Stack
A closer look at the technologies used by BioMarin
See more technologies
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioMarin
Sign Up For FreeTo access detailed company insights
BioMarin Pharmaceutical Inc. is a global biotechnology company headquartered in San Rafael, California, founded in 1997. The company develops and commercializes therapies for rare, genetically defined diseases, with a focus on enzyme replacement and other specialized treatments. Its portfolio includes therapies for mucopolysaccharidosis, phenylketo... Read More


